Welcome to our dedicated page for CRE8 ENTERPRISE SEC filings (Ticker: CRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cre8 Enterprise Limited SEC filings document foreign private issuer current reports for a Hong Kong-based integrated financial printing service provider. The filings cover material events reported on Form 6-K, including the completed acquisition of Upperhand Investment Limited and its Japan operating subsidiary, Nasdaq minimum bid price compliance, and the company’s Class A and Class B ordinary share structure.
The filing record also documents capital actions and public-company disclosures, including the 1-for-12 reverse stock split, related adjustments to options, warrants and convertible securities, the full exercise of the IPO over-allotment option, press releases furnished as exhibits, and service-related updates such as cryptocurrency payment acceptance for clients.
Cre8 Enterprise Limited pre-IPO shareholders Mr. Seng Jin LEE and Cre8 Investments Limited filed a Schedule 13D disclosing beneficial ownership of 6,435,000 Class A ordinary shares and 4,500,000 Class B ordinary shares. Based on the issuer's prospectus and Form 6-K, these holdings represent approximately 32.72% of Class A and 87.93% of the aggregate voting power of issued Class A and Class B shares because each Class B share carries 20 votes versus one vote for each Class A share. An Acting-in-Concert Agreement designates Mr. Seng Jin LEE as sole representative with exclusive authority to direct the vote of the parties to that agreement. The shares were acquired through the issuer's group reorganization in connection with its incorporation and IPO preparation.
Cre8 Enterprise Limited (NASDAQ: CRE) disclosed that American Trust Investment Services, acting as lead underwriter, fully exercised the IPO over-allotment option on 28 Jul 2025. The option covered 217,500 Class A ordinary shares at the original offering price of US$4.00 per share; closing occurred on 30 Jul 2025.
The exercise supplied an extra US$0.87 million in gross proceeds, bringing total IPO gross proceeds to US$6.67 million before underwriting discounts and related expenses. A press release detailing the transaction is included as Exhibit 99.1.
The full greenshoe take-up indicates healthy aftermarket demand and adds incremental liquidity for corporate uses, albeit with a slight increase in share count and dilution to existing holders.